Figure 1From: The impact of statin use on pneumonia risk and outcome: a combined population-based case-control and cohort studyStatin dose and pneumonia risk and mortality. Dose-response associations between the number of defined daily doses (DDDs) of statins per day received within 125 days of the admission/index date and pneumonia hospitalization odds ratios (a) and hazard ratios for death (b). The relationship between DDDs and pneumonia was assessed by dividing DDDs into percentiles of users. OR, odds ratio.Back to article page